PPA
NERV icon

Parametric Portfolio Associates’s Minerva Neurosciences NERV Stock Holding History

Parametric Portfolio Associates’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,456
Closed -$27K – 4071
2020
Q4 		$27K Sell
1,456
-429
-23% -$10.8K ﹤0.01% 3969
2020
Q3 		$48K Sell
1,885
-14
-0.7% -$378 ﹤0.01% 3871
2020
Q2 		$55K Sell
1,899
-336
-15% -$19.7K ﹤0.01% 3853
2020
Q1 		$108K Sell
2,235
-153
-6% -$9.23K ﹤0.01% 3720
2019
Q4 		$136K Buy
2,388
+469
+24% +$20.7K ﹤0.01% 3814
2019
Q3 		$119K Buy
1,919
+667
+53% +$37.8K ﹤0.01% 3803
2019
Q2 		$56K Buy
+1,252
New +$62.7K ﹤0.01% 3901
2016
Q4 		– Sell
-1,773
Closed -$200K – 3794
2016
Q3 		$200K Buy
1,773
+460
+35% +$44.6K ﹤0.01% 3574
2016
Q2 		$107K Buy
+1,313
New +$83.5K ﹤0.01% 3718

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Parametric Portfolio Associates's NERV Position: Q1 2021 in Review

Parametric Portfolio Associates sold out of Minerva Neurosciences (NERV) in Q1 2021, closing a stake of 1,456 shares — an estimated $27K sold.

Parametric Portfolio Associates first reported a position in NERV in Q2 2016 and held it in 9 quarters. The position peaked at $200K in Q3 2016. 72 funds tracked by Wall St. Rank hold NERV as of Q1 2021.

  • Parametric Portfolio Associates reported no remaining Minerva Neurosciences position as of Q1 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,456 Minerva Neurosciences shares in Q1 2021, an estimated $27K.
  • Parametric Portfolio Associates first reported a position in Minerva Neurosciences in Q2 2016 and held it in 9 quarters.
  • Parametric Portfolio Associates's Minerva Neurosciences position peaked at $200K in Q3 2016.
  • 72 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2021.

Based on Parametric Portfolio Associates's 13F filing for Q1 2021, filed 17 May 2021.